Abstract:Background: Hepatocellular carcinoma (HCC) is the second lethal malignancy among all cancers. Many molecular alterations have been found in HCC. However, the interactions and modulatory mechanisms among these molecules in HCC are still unclear. Methods: CTB-193M12.5 expression in tissues and cells were detected by quantitative polymerase chain reaction (qPCR). In vitro experiments were conducted to evaluate the function of CTB-193M12.5 in cell proliferation, apoptosis, migration and invasion. The interaction between CTB-193M12.5 and nuclear receptor binding SET domain-containing protein 1 (NSD1) was assessed by RNA??? protein pull-down and RNA immunoprecipitation assays. The roles of CTB-193M12.5 on WNT10B and Wnt/??-catenin signaling was detected by chromatin immunoprecipitation assay, qPCR, Western blot, and dual luciferase reporter assay. Results: We identified a novel prognosis-related long noncoding RNA (lncRNA) CTB-193M12.5 in HCC. CTB-193M12.5 was upregulated in HCC and its high expression was correlated with alpha fetoprotein, large tumor size, aggressive clinical characteristics, and poor survival. Functional experiments showed that CTB-193M12.5 enhanced HCC cellular proliferation, suppressed HCC cellular apoptosis, and promoted HCC cellular migration and invasion. CTB-193M12.5 knockdown exerted opposite effects in HCC. Mechanistic investigation demonstrated that CTB-193M12.5 was mainly distributed in nucleus. Histone methyltransferase NSD1 was identified as a CTB-193M12.5 interactor. CTB-193M12.5 bound and recruited NSD1 to the promoter of WNT10B, leading to an increase in di-methylation of histone H3 at lysine 36 (H3K36me2) and the reduction of tri-methylation of histone H3 at lysine 27 (H3K27me3) at WNT10B promoter. Therefore, CTB-193M12.5 epigenetically activated WNT10B transcription. Through upregulating WNT10B, CTB-193M12.5 further activated Wnt/??-catenin signaling. Functional rescue experiments demonstrated that overexpression of WNT10B reversed the tumor suppressive roles of CTB-193M12.5 knockdown, while Wnt/??-catenin signaling inhibitor ICG-001 abolished the oncogenic roles of CTB-193M12.5 overexpression. Conclusion: CTB-193M12.5 was a highly expressed and poor prognosis-related lncRNA in HCC. CTB-193M12.5 functioned as an oncogenic lncRNA through promoting NSD1-mediated WNT10B/Wnt/??-catenin signaling activation.

CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.

CtBP2 Overexpression Promotes Tumor Cell Proliferation and Invasion in Gastric Cancer and is Associated with Poor Prognosis

CtBP1 Interacts with SOX2 to Promote the Growth, Migration and Invasion of Lung Adenocarcinoma.

C-terminal Binding Protein-2 Promotes Cell Proliferation and Migration in Breast Cancer Via Suppression of P16ink4a

Silencing of CtBP1 suppresses the migration in human glioma cells

C-Terminus of E1A Binding Protein 1 Stimulates Malignant Phenotype in Human Hepatocellular Carcinoma.

CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1

Interaction with CCNH/CDK7 Facilitates CtBP2 Promoting Esophageal Squamous Cell Carcinoma (ESCC) Metastasis Via Upregulating Epithelial-Mesenchymal Transition (EMT) Progression.

CtBP2 is Associated with Angiogenesis and Regulates the Apoptosis of Prostate Cancer Cells.

Author Correction: Integrin Β4 Promotes Cell Invasion and Epithelial-Mesenchymal Transition Through the Modulation of Slug Expression in Hepatocellular Carcinoma

Orosomucoid 2 Inhibits Tumor Metastasis and is Upregulated by CCAAT/enhancer Binding Protein Β in Hepatocellular Carcinomas

TATA-box-binding Protein Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-Mesenchymal Transition.

Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.

C-terminal binding protein: Regulator between Viral Infection and Tumorigenesis

CtBP1/2 Differentially Regulate Genomic Stability and DNA Repair Pathway in High-Grade Serous Ovarian Cancer Cell

Gli1 Overexperssion Contributes To Hcc Recurrence Partly Through The Induction Of Snai1-Induced Epithelial-To-Mesenchymal Transition

Upregulation of a Novel LncRNA AC104958.2 Stabilized by PCBP2 Promotes Proliferation and Microvascular Invasion in Hepatocellular Carcinoma.

Caveolin-1 Is Up-Regulated By Gli1 And Contributes To Gli1-Driven Emt In Hepatocellular Carcinoma

Invasive Potential of Hepatocellular Carcinoma is Enhanced by Loss of Selenium-Binding Protein 1 and Subsequent Upregulation of CXCR4

SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p

CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression Via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation